Glioma‐derived cancer stem cells are hypersensitive to proteasomal inhibition

Autor: Joonsung Hwang, Sang Cheul Oh, Shin Hyuk Kang, Ki Sa Sung, Dae Hee Lee, Su Ran Mun, Hyungsin Kim, Young Dong Yoo, Changhoon Ji, Seong Hye Park, Kyung Jae Park, Deric M. Park, Yong J. Lee, Seung-Ki Kim, Kim Bo Yeon, Seung Ah Choi, Aaron Ciechanover, Yong Tae Kwon, Hyunjoo Cha-Molstad
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Apoptosis
medicine.disease_cause
Biochemistry
Mice
0302 clinical medicine
Tumor Cells
Cultured

Kinase
NF-kappa B
Glioma
Articles
Cell biology
Gene Expression Regulation
Neoplastic

030220 oncology & carcinogenesis
Neoplastic Stem Cells
Stem cell
Corrigendum
Proteasome Inhibitors
Signal Transduction
Proteasome Endopeptidase Complex
endocrine system
Cell Survival
Antineoplastic Agents
Biology
Models
Biological

03 medical and health sciences
Cancer stem cell
Cell Line
Tumor

medicine
Genetics
Animals
Humans
Molecular Biology
Endoplasmic reticulum
fungi
JNK Mitogen-Activated Protein Kinases
Ubiquitination
medicine.disease
Xenograft Model Antitumor Assays
Disease Models
Animal

030104 developmental biology
Proteasome
Drug Resistance
Neoplasm

Cancer research
Unfolded protein response
Carcinogenesis
Biomarkers
030215 immunology
Popis: Although proteasome inhibitors (PIs) are used as anticancer drugs to treat various cancers, their relative therapeutic efficacy on stem cells vs. bulk cancers remains unknown. Here, we show that stem cells derived from gliomas, GSCs, are up to 1,000‐fold more sensitive to PIs (IC 50, 27–70 nM) compared with their differentiated controls (IC 50, 47 to »100 μM). The stemness of GSCs correlates to increased ubiquitination, whose misregulation readily triggers apoptosis. PI‐induced apoptosis of GSCs is independent of NF‐κB but involves the phosphorylation of c‐Jun N‐terminal kinase as well as the transcriptional activation of endoplasmic reticulum (ER) stress‐associated proapoptotic mediators. In contrast to the general notion that ER stress‐associated apoptosis is signaled by prolonged unfolded protein response (UPR), GSC‐selective apoptosis is instead counteracted by the UPR. ATF3 is a key mediator in GSC‐selective apoptosis. Pharmaceutical uncoupling of the UPR from its downstream apoptosis sensitizes GSCs to PIs in vitro and during tumorigenesis in mice. Thus, a combinational treatment of a PI with an inhibitor of UPR‐coupled apoptosis may enhance targeting of stem cells in gliomas.
Databáze: OpenAIRE